Association of serum brain‐derived neurotrophic factor level and early response to antipsychotic drug in first‐episode patients with schizophrenia
International Journal of Methods in Psychiatric Research · 2024-03 · 33 (1)
DOI: 10.1002/mpr.1982 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Methods in Psychiatric Research, online erschienen am 23.07.2023. Verfasst von Tong Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, QuZhou Third Municipal Hospital, QuZhou, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xinxiang Medical University Doctor Startup Fund, Huzhou Science and Technology Program Project, Zhejiang Provincial Medical and Health Science and Technology Program Project.
Abstract (Originalsprache)
Objectives
To investigate the role of Brain derived neurotrophic factor (BDNF) in the psychotic symptoms in first‐episode patients with schizophrenia and whether BDNF levels were associated with the improvement of psychotic symptoms after risperidone treatment.
Methods
89 schizophrenia patients and 90 healthy controls were recruited, the schizophrenia patients were assigned into early response or early non‐response groups at 2 weeks based on improvement in the positive and negative symptoms scale (PANSS) total score. All patients were treated with risperidone for 2 weeks, their serum BDNF levels were compared at baseline and after 2 weeks treatment.
Results
We found that patients had lower BDNF levels, compared to controls at baseline. After 2 weeks of treatment of risperidone, BDNF levels were significantly increased and psychotic symptoms were decreased in early response group. Correlation analysis showed that the change of BDNF levels after treatment was correlated with the change of PANSS total score. Further regression analysis showed that the change in BDNF levels was an independent predictor for the improvement in psychotic symptoms.
Conclusions
Our findings reveal that the level of BDNF was lower in first‐episode schizophrenic patients, moreover, the changes in serum BDNF levels may have a predictive effect on the early improvement in psychotic symptoms in the first 2 weeks.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, QuZhou Third Municipal Hospital, QuZhou, China.
- Department of Psychiatry, Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou University, Huzhou, China.
- School of Nursing, Xinxiang Medical University, Xinxiang, Henan, China.
- Department of Psychiatry, The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
- The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
ORCID-Profile: GuangBiao Huang
Förderung
- Xinxiang Medical University Doctor Startup Fund
- Huzhou Science and Technology Program Project
- Zhejiang Provincial Medical and Health Science and Technology Program Project
- Open Program of Henan Key Laboratory of Biological Psychiatry
Zitieren
APA
Zhao, T., Tang, S., Gao, X., Li, J., Hao, R., Chen, H., & Huang, G. (2024). Association of serum brain‐derived neurotrophic factor level and early response to antipsychotic drug in first‐episode patients with schizophrenia. International Journal of Methods in Psychiatric Research, 33(1). https://doi.org/10.1002/mpr.1982
Vancouver
Zhao T, Tang S, Gao X, Li J, Hao R, Chen H, et al. Association of serum brain‐derived neurotrophic factor level and early response to antipsychotic drug in first‐episode patients with schizophrenia. International Journal of Methods in Psychiatric Research. 2024;33(1). doi:10.1002/mpr.1982
BibTeX
@article{Zhao2024,
author = {Zhao, Tong and Tang, SuFang and Gao, XiaoLei and Li, Juan and Hao, Ran and Chen, HaiZhi and Huang, GuangBiao},
title = {Association of serum brain‐derived neurotrophic factor level and early response to antipsychotic drug in first‐episode patients with schizophrenia},
journal = {International Journal of Methods in Psychiatric Research},
year = {2024},
volume = {33},
number = {1},
doi = {10.1002/mpr.1982}
}
EUVIMED